VistaGen Therapeutics (VTGN) Receives Notice of Allowance for Additional US Patent Regarding Methods of Production for AV-101 StreetInsider.com
VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for depression and other central …